Dysbiosis in inflammatory bowel disease - PubMed (original) (raw)

Dysbiosis in inflammatory bowel disease

C P Tamboli et al. Gut. 2004 Jan.

Abstract

Abundant data have incriminated intestinal bacteria in the initiation and amplification stages of inflammatory bowel diseases. However, the precise role of intestinal bacteria remains elusive. One theory has suggested a breakdown in the balance between putative species of "protective" versus "harmful" intestinal bacteria--this concept has been termed "dysbiosis". Arguments in support of this concept are discussed.

PubMed Disclaimer

Comment in

• Dysbiosis as a prerequisite for IBD.
  Tamboli CP, Neut C, Desreumaux P, Colombel JF. Tamboli CP, et al. Gut. 2004 Jul;53(7):1057. Gut. 2004. PMID: 15194668 Free PMC article. No abstract available.

References

1. 1. Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002;347:417–29. - PubMed
2. 1. Shanahan F. Crohn’s disease. Lancet 2002;359:62–9. - PubMed
3. 1. Girardin SE, Travassos LH, Herve M, et al. Peptidoglycan molecular requirements allowing detection by Nod1 and Nod2. J Biol Chem 2003;278:41702–8. - PubMed
4. 1. Inohara N, Ogura Y, Fontalba A, et al. Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn’s disease. J Biol Chem 2003;278:5509–12. - PubMed
5. 1. Hisamatsu T, Suzuki M, Reinecker HC, et al. CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells. Gastroenterology 2003;124:993–1000. - PubMed

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • HighWire
  • Ovid Technologies, Inc.
  • PubMed Central

• Other Literature Sources

  • The Lens - Patent Citations Database